📰 Spinogenix Inc News
Spinogenix Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Spinogenix Inc. Real-time updates on events, politics, business and more.
May 29, 2024
DoD banned wound training, weapons, trauma experiments on dogs, cats and primates in 1980s but still abuses and kills dogs in other experiments, group claims.
July 10, 2023
SAN DIEGO, July 10, 2023 (GLOBE NEWSWIRE) -- Spinogenix, Inc., a clinical-stage biopharmaceutical company developing novel small molecule drugs for...
April 11, 2023
/PRNewswire/ -- The Alzheimers disease therapeutics market size is forecast to increase by USD 4,391.9 million from 2022 to 2027, at a CAGR of 8.91%,...
April 3, 2023
Global Alzheimer’s Disease Therapeutics Market 2023-2027. The analyst has been monitoring the Alzheimer’s disease therapeutics market and is forecast to...
February 9, 2023
/PRNewswire/ -- The Alzheimers Disease Therapeutics Market by Drug Class and Geography - Forecast and Analysis 2022-2026 report has been published by...
November 14, 2022
/PRNewswire/ -- The Alzheimers disease therapeutics market is projected to grow by USD 3.99 billion, accelerating at a CAGR of 8.76% from 2021 to 2026. 37% of...
November 14, 2022
/PRNewswire/ -- The Alzheimers disease therapeutics market is projected to grow by USD 3.99 billion, accelerating at a CAGR of 8.76% from 2021 to 2026. 37% of...
September 28, 2022
/PRNewswire/ -- The global Alzheimers disease therapeutics market size is expected to grow by USD 3.99 billion, accelerating at a CAGR of 8.76% between 2021...
April 26, 2022
/PRNewswire/ -- The Alzheimers Disease Therapeutics Market share is expected to grow by USD 3.99 billion from 2021 to 2026 during the forecast period,...